Dopamine Agents < Dopamine Agonists < Dopamine Antagonists

Facettes :

List of bibliographic references indexed by Dopamine Agonists

Number of relevant bibliographic references: 72.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000429 (2016)	Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip Seeman	Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
000483 (2015)	James A. G. Crispo [États-Unis] ; Yannick Fortin ; Dylan P. Thibault [États-Unis] ; Matthew Emons [États-Unis] ; Lise M. Bjerre ; Dafna E. Kohen ; Santiago Perez-Lloret [Argentine] ; Donald Mattison ; Allison W. Willis [États-Unis] ; Daniel Krewski	Trends in inpatient antiparkinson drug use in the USA, 2001–2012
000542 (2015)	Tanja Tran [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada] ; Christel Renoux [Canada]	Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
000581 (2015)	Alberto J. Espay ; Matthew M. Norris ; James C. Eliassen ; Alok Dwivedi ; Matthew S. Smith ; Christi Banks ; Jane B. Allendorfer ; Anthony E. Lang ; David E. Fleck ; Michael J. Linke ; Jerzy P. Szaflarski	Placebo effect of medication cost in Parkinson disease
000585 (2015)	Michele Tinazzi ; Alfonso Fasano ; Christian Geroin ; Francesca Morgante ; Roberto Ceravolo ; Simone Rossi ; Astrid Thomas ; Giovanni Fabbrini ; Annarita Bentivoglio ; Filippo Tamma ; Giovanni Cossu ; Nicola Modugno ; Mario Zappia ; Maria Antonietta Volontè ; Carlo Dallocchio ; Giovanni Abbruzzese ; Claudio Pacchetti ; Roberto Marconi ; Giovanni Defazio ; Margherita Canesi ; Antonino Cannas ; Antonio Pisani ; Rina Mirandola ; Paolo Barone ; Carmine Vitale	Pisa syndrome in Parkinson disease: An observational multicenter Italian study.
000601 (2015)	Philip Seeman [Canada]	Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
000642 (2015)	I. Aracil-Bola Os [Canada] ; A. P. Strafella [Canada]	Molecular imaging and neural networks in impulse control disorders in Parkinson’s disease
000748 (2015)	Mariano Serrao [Italie] ; Alberto Ranavolo [Italie] ; Carmela Conte [Italie] ; Chiara Davassi [Italie] ; Silvia Mari [Italie] ; Alfonso Fasano [Canada] ; Giorgia Chini [Italie] ; Gianluca Coppola [Italie] ; Francesco Draicchio [Italie] ; Francesco Pierelli [Italie]	Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.
000752 (2015)	Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie]	Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
000769 (2015)	Mateusz Zurowski [Canada] ; Jonathan Darcy O'Brien	Developments in impulse control behaviours of Parkinson's disease.
000827 (2015)	María Sierra [Espagne] ; Sébastien Carnicella [France] ; Antonio P. Strafella [Canada] ; Amélie Bichon [France] ; Eugénie Lhommée [France] ; Anna Castrioto [France] ; Stephan Chabardes [France] ; Stéphane Thobois [France] ; Paul Krack [France]	Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.
000937 (2014)	Donald A. Mcafee [Canada] ; Jonathan Hadgraft [Royaume-Uni] ; Majella E. Lane [Royaume-Uni]	Rotigotine: the first new chemical entity for transdermal drug delivery.
000938 (2014)	Camila C. Aquino [Brésil] ; Tiago Mestre [Canada] ; Anthony E. Lang [Canada]	Restless genital syndrome in Parkinson disease.
000941 (2014)	Thomas J. Moore [États-Unis] ; Joseph Glenmullen [États-Unis] ; Donald R. Mattison [Canada]	Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
000970 (2014)	Ronald B. Postuma [Canada] ; Roger L. Albin	Placebo: from belief to movement.
000A30 (2014)	Anthony E. Lang [Canada] ; Connie Marras [Canada]	Initiating dopaminergic treatment in Parkinson's disease.
000A45 (2014)	Franziska Maier [Allemagne] ; Josuah Merkl [Allemagne] ; Anna L. Ellereit [Allemagne] ; Catharine J. Lewis [Allemagne] ; Carsten Eggers [Allemagne] ; David J. Pedrosa [Allemagne] ; Elke Kalbe [Allemagne] ; Jens Kuhn [Allemagne] ; Thomas D. Meyer [Royaume-Uni] ; Mateusz Zurowski [Canada] ; Lars Timmermann [Allemagne]	Hypomania and mania related to dopamine replacement therapy in Parkinson's disease.
000D75 (2013)	Abdul Qayyum Rana [Canada] ; Wasim Mansoor ; Syed Hussaini ; Abdullah Al Mosabbir ; Maniza Rahman ; Labiba Rahman	Factors associated with the development of impulse compulsive disorders in Parkinson patients.
000D99 (2013)	Francesca Antonelli [Canada] ; Ji Hyun Ko [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Franco Valzania [Italie] ; Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada]	Dopamine-Agonists and Impulsivity in Parkinson’s Disease: Impulsive Choices vs. Impulsive Actions
000F04 (2013)	Margarita Pondal [Canada] ; Connie Marras [Canada] ; Janis Miyasaki [Canada] ; Elena Moro [Canada] ; Melissa J. Armstrong [Canada] ; Antonio P. Strafella [Canada] ; Binit B. Shah [Canada] ; Susan Fox [Canada] ; L K Prashanth [Canada] ; Nicolas Phielipp [Canada] ; Anthony E. Lang [Canada]	Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
001234 (2012)	Nicola J. Ray [Canada] ; Janis M. Miyasaki [Canada] ; Mateusz Zurowski [Canada] ; Ji Hyun Ko [Canada] ; Sang Soo Cho [Canada] ; Giovanna Pellecchia [Canada] ; Francesca Antonelli [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada]	Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Dopamine Agonists" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Dopamine Agonists" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine Agonists
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022